KLF5 regulation of intestinal development and stem cell homeostasis.
KLF5 regulation of intestinal development and stem cell homeostasis.
批准号:
8486426
负责人:
NOAH Freeman SHROYER
金额:
$37.71万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-05 至 2014-05-31
关键词:
AdultBioinformaticsBiological AssayBrush BorderCell CycleCell TherapyCellsCyclinsDNA BindingDataDevelopmentELF3 geneEmbryoEndodermEnterocytesEnteroendocrine CellEpithelialFailureFutureGene TargetingGenesGenetic EpistasisGoalsGoblet CellsGrowthHindgutHomeostasisHumanHuman DevelopmentIn VitroInfantIntestinal DiseasesIntestinesKnowledgeLifeMethodsModelingMorphogenesisMusNecrotizing EnterocolitisOncogenicOrganOrganoidsPaneth CellsPatientsPluripotent Stem CellsRegulationReporterResourcesRoleStem Cell DevelopmentStem cellsStructure of intestinal glandSystemTestingTissuesTransgenic MiceVillusZinc Fingersembryonic stem cellgastrointestinal epitheliumgastrulationin vivoinduced pluripotent stem cellinsightintestinal homeostasisintestinal villinovelpostnatalpreventprogenitorpromoterresearch studyself-renewalstem cell divisiontranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The factors that control intestinal development and stem cell homeostasis remain inadequately characterized. Kruppel like factor 5 (KLF5, also termed IKLF or BTEB2) is a zinc-finger transcription factor that is thought to regulate proliferation and differentiation of gastrointestinal epithelia. KLF5 is highly expressed in the early embryo and the primordial endoderm during gastrulation, with continued expression in the mid/hindgut and embryonic intestine during morphogenesis and cytodifferentiation. During postnatal emergence of intestinal progenitor do- mains (crypts of Lieberkuhn), KLF5 becomes restricted to the crypts and its expression is maintained in this pro- genitor zone throughout life. In this context, KLF5 is hypothesized to promote proliferation by regulating cell cycle machinery such as cyclins, and has a role in oncogenic transformation. However, KLF5's role in embryonic and adult intestinal stem cell self-renewal and differentiation remains untested. Here, we propose to test the hypothesis that KLF5 controls self-renewal and differentiation of both embryonic and adult intestinal stem cells. In preliminary studies, we developed transgenic mice in which KLF5 can be inducibly deleted or activated in the intestine, as a means to investigate the function of KLF5 in vivo. These data show that KLF5 has an essential role in regulating proliferation and differentiation of intestinal stem cell/progenitors. We have also established a novel method to direct development of human pluripotent stem cells (PSCs, embryonic stem cells and induced pluripotent stem cells) into intestinal organoids in vitro, and show that KLF5 is expressed at key developmental steps in this system. In this proposal, we will utilize these unique resources to define the role of KLF5 in regulating self-renewal and differentiation in the intestine. Three aims will be pursued: 1.) Define the requirement and sufficiency for KLF5 to control intestinal development. Hypothesis: Loss of KLF5 will result in impaired intestinal morphogenesis and cytodifferentiation, whereas increased expression of KLF5 will direct embryonic intestinal progenitors to precociously differentiate. We will manipulate KLF5 expression in order to define KLF5's role in embryonic intestinal development, using human PSC-derived intestinal organoids and transgenic mice. 2.) Determine the requirement and sufficiency for KLF5 to control adult intestinal stem cell homeostasis. Hypothesis: Loss of KLF5 will block differentiation and promote expansion of stem cells, whereas pan-epithelial KLF5 will deplete the stem cell pool. Using adult transgenic mice and crypt-derived epithelial organoids, intestinal stem cell homeostasis will be defined under conditions of inducible KLF5 manipulation. 3.) Define key targets of KLF5 that regulate embryonic morphogenesis and adult intestinal homeostasis. We have identified putative downstream effectors of KLF5 using microarray and bioinformatic approaches. To gain insight into the mechanisms of KLF5 action, epistasis analysis will be performed with target genes to test their ability to control differentiation and homeostasis in KLF5-manipulatable embryonic and adult intestinal organ/oid culture. Direct KLF5 targets will be identified by DNA binding and promoter reporter assays.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
-
批准号:10454085
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2022
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Mechanisms of telomere-induced disease: Role of intestinal malabsorption, barrier dysfunction and dsybiosis.
-
批准号:10632001
-
项目类别:
-
资助金额:$64.89万
-
财政年份:2022
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The Gastrointestinal Experimental Model Systems (GEMS) Core
-
批准号:10117232
-
项目类别:
-
资助金额:$17.6万
-
财政年份:2020
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Mechanisms of intestinal stem cell differentiation and plasticity.
-
批准号:9788430
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2018
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Enteroid Core
-
批准号:8855933
-
项目类别:
-
资助金额:$15.06万
-
财政年份:2015
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Endocrine Cell Development
-
批准号:8295786
-
项目类别:
-
资助金额:$45.5万
-
财政年份:2012
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Human Endocrine Cell Development
-
批准号:8456068
-
项目类别:
-
资助金额:$43.91万
-
财政年份:2012
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis
-
批准号:8905197
-
项目类别:
-
资助金额:$40.22万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis.
-
批准号:8294532
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
KLF5 regulation of intestinal development and stem cell homeostasis.
-
批准号:8162496
-
项目类别:
-
资助金额:$44.94万
-
财政年份:2011
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8433478
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8033791
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:7768927
-
项目类别:
-
资助金额:$31.56万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:9093525
-
项目类别:
-
资助金额:$29.87万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
The role of ATOH1 as a tumor suppressor in colorectal cancer
-
批准号:8228178
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2010
-
负责人:NOAH Freeman SHROYER
-
依托单位:
SPDEF in intestinal differentiation.
-
批准号:7893824
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2009
-
负责人:NOAH Freeman SHROYER
-
依托单位:
SPDEF in intestinal differentiation.
-
批准号:7708206
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2009
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7342355
-
项目类别:
-
资助金额:$13.29万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7253102
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
Intestinal secretory lineage development and function
-
批准号:7478746
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2005
-
负责人:NOAH Freeman SHROYER
-
依托单位:
海外基金